Beta-thalassemia is one of the most frequently occurring hematological disorders in
[Removed for blinded peer-review]. Regular blood transfusion is required in almost all cases …

Red blood cell alloimmunization is one of the major challenges to regular transfusions in β-
thalassemic patients. In Morocco, rare studies have focused on this hemoglobinopathy …

In this study, we aimed to determine the frequency of red cell allo-and autoimmunization and
analyze the factors responsible for the development of antibodies in patients with transfusion …

Objective: Frequency of red cell ALLOIMMUNIZATION in patients with b-major-
THALASSEMIA in Mofid children's hospital. Tehran. Iran. Material & Methods: This is a cross …

Background Multiple transfusions in thalassemia patients may lead to antibody production
against blood group antigens and hemolytic transfusion reaction might occur. In this study …

Background: The mainstay of managing severe β-thalassemia remains lifelong blood
transfusion. Mismatched red blood cell phenotypes between donors and recipients in …

Background Transfusion‐dependent thalassemia patients are at high risk of transfusion‐
related complications. Yet, there is scanty data on the frequency of transfusion reactions …

Background: The thalassemias are hereditary hemolytic anemias characterized by reduced
or absent synthesis of one or more of globin chains of hemoglobin leading to globin chain …

Patients with beta thalassemia major (TM) are transfusion-dependent (TD) since early
childhood and for life. Development of alloantibodies and autoantibodies against red blood …

Background: Recurrent blood transfusion is a common treatment in patients with
thalassemia. The development of antibodies against red blood cell (RBC) antigens …